Oslo Medicines Initiative

A new vision for collaboration between the public and private sectors

Monday, 27 September 2021 | 11:00-12:30 | Room 1

Organised by WHO Regional Office for Europe, the Norwegian Ministry of Health and Care Services, and the Norwegian Medicines Agency

Launched at the EHFG last year, the Oslo Medicines Initiative (OMI) aims to build a collaborative platform where stakeholders can come together to identify actions to improve patient-access to effective high cost novel medicines across the European Region.

Continuing dialogue with all stakeholders is paramount to find common ground and agree to transparent, sustainable solutions that are of mutual benefit to Member-States and non-State actors, including health systems, payers, patients, and industry). The initiative aims to reshape the political discourse, implement pragmatic step-by-step solutions, and create partnerships to build a movement for systemic change.

Supported by consultations, background documents and webinars, OMI will culminate in a high-level meeting in Oslo on 13-14 June 2022. OMI is a unique opportunity for stakeholders to discuss some of the major challenges and collectively agree on new opportunities for collaboration. Join us in this session to envision a sustainable future for better access to medicines across Europe and beyond!

Session Recording

Speakers & panellists

  • Thomas Allvin, Executive Director Strategy and Healthcare Systems, European Federation of Pharmaceutical Industries and Associations
  • Yann Le Cam, Chief Executive Officer, EURORDIS-Rare Diseases Europe
  • Jo De Cock, Health Systems Advisor, Belgium
  • Sarah Garner, Acting Programme Manager, Access to Medicines and Health Products, WHO Regional Office for Europe
  • Sylvian Giraud, Head of Unit, Medical Products: Quality, Safety and Innovation, European Commission Directorate-General for Health and Food Safety
  • Jens Grueger, Director, Boston Consulting Group
  • Hans Henri P. Kluge, Regional Director for Europe, World Health Organization
  • Bjørn-Inge Larsen, Special representative for international health, Norwegian Ministry of Health and Care Services
  • Elizabeth Kuiper, Associate Director and Head of the Social Europe and Wellbeing Programme, European Policy Centre

Moderated by

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kurgartenstraße, 5630 Bad Hofgastein, Austria